Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine, MHRA (published 9th December 2020)

MHRA has advised that any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer/BioNTech vaccine; and a second dose should not be given to anyone who has experienced anaphylaxis following administration of the first dose of this vaccine.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news